Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-interventional Study to Assess the Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma (FL)

NCT03568929 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT03568929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03568929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-interventional Study to Assess the Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma (FL)
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
May 25, 2018
Completion date
October 29, 2021
Enrollment
257 (actual)
Sites
88

Conditions

As the registry lists them; a condition with its own page is linked.

follicular non-hodgkin's lymphoma refractory